Transcript
Page 1: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VENTILATOR ASSOCIATED PNEUMONIA (VAP)

Dr.Tinku JosephDM Resident

Department of Pulmonary MedicineAIMS, Kochi

Email: [email protected]

Page 2: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Ventilator-associated pneumonia (VAP) is a type of HAP that develops more than 48 to 72 hours after endotracheal intubation.

Hospital-acquired (or nosocomial) pneumonia (HAP) is pneumonia that occurs 48 hours or more after admission and did not appear to be incubating at the time of admission.

Definition- “Know the enemy”

(ATS/IDSA) guidelines 2005

Page 3: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Healthcare-associated pneumonia (HCAP) is defined as pneumonia that occurs in a nonhospitalized patient with extensive healthcare contact, as defined by one or more of the following:

Intravenous therapy, wound care, or intravenous chemotherapy within the prior 30 days

Residence in a nursing home or other long-term care facility Hospitalization in an acute care hospital for two or more days

within the prior 90 days Attendance at a hospital or hemodialysis clinic within the

prior 30 days

Definition- “Know the enemy”

(ATS/IDSA) guidelines 2005

Page 4: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Definition- “Know the enemy” Typically in studies, patients are only included if

intubated greater than 48 hours Early onset= less than 4 days Late onset= greater than 4 days

Endotracheal intubation increases risk of developing pneumonia by 6 to 21 fold

Accounts for 90% of infections in mechanically ventilated patients

American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated,

and healthcare-associated pneumonia.

Page 5: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Page 6: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Age >70 years Severe Illness Underlying Lung Disease Depressed Mental Status Immunocompromising conditions Viral Respiratory Tract Infection Treatments Agents that increase gastric pH (H2 blockers,

antacids, proton pump inhibitors) Previous antibiotic exposure, particularly to third-

generation cephalosporins. Paralytic agents

Host Factors

Page 7: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Intensive Care Setting Use of Antimicrobial Agents Contaminated hands Contaminated Equipment

Colonisation

Page 8: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Colonisation

Page 9: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Mechanical ventilation Tracheostomy Use of a Nasogastric Tube Supine Position

Factors that facilitate reflux & aspiration into the lower RT

Page 10: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Risk Factors

Abdominal or thoracic surgery

Immobilisation

Factors that impede normal Pulmonary Toilet

Page 11: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Why in ICU patients ??

Page 12: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP Types

Page 13: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Early v/s late VAP

Page 14: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP occurs in 10 - 65% of all ventilated patients Crit Care Clin (2002)

Incidence increases with duration of MV 3% /day for first 5days, 2%/day for 6-10days and 1%/day after 10 days.

Mortality rate is 27% &43%with antibiotic resistant organism.

critical care societies collaborative(CCSCs) Mortality rate in VAP caused by Pseudomonas or

Acinetobacter is as high as 76% Crit Care Med (2004)

Incidence

Page 15: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Increases ventilatory support requirements and ICU

stay by 4.3 days Increases hospital LOS by 4 to 9 days

Increases medical cost

Chest 2002;122:2115 Critical Care Medicine 2005;33:2184-93

Incidence

Page 16: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Pathogenesis

Bacteria enter the lower respiratory tract via following pathways:– Aspiration of organisms from the oropharynx and

GI tract (most common cause)– Direct inoculation– Inhalation of bacteria– Haematogeneous spread

Page 17: ventilator Associated Pneumonia -By Dr.Tinku Joseph

ASPIRATION- primary route of bacterial entry into LRT

ENDOTACHEAL TUBE Holds the vocal cords open-predispose to micro & macro aspiration of colonized bacteria from oropharynx to LRT.Leakage of secretion containing bacteria around the ETT cuff.

Page 18: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 19: ventilator Associated Pneumonia -By Dr.Tinku Joseph

• NGT OR OROGASTRIC TUBE • Interrupt gastro-esophageal sphincter leading

GI reflux and aspiration. Increase oropharyngeal colonization, stagnation of oropharyngeal and nasal secretion.

Pathogenesis

Page 20: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Inhalation of aerosols containing bacteria : -Contaminated RT equipment -From other patients/ healthcare personnel's -Inadequate disinfection/sterilization technique -Contaminated solutions/waterDirect contact:

-Cross Contamination (Hands)

Pathogenesis

Page 21: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 22: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Pathogenesis

Page 23: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Pathogenesis

Page 24: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP Pathogenesis

Page 25: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 26: ventilator Associated Pneumonia -By Dr.Tinku Joseph

MDR Pathogens

• Host risk factors for infection with MDR pathogens include :

Receipt of antibiotics within the preceding 90 days Current hospitalization of ≥5 days High frequency of antibiotic resistance in the community

or in the specific hospital unit. Immunosuppressive disease and/or therapy Severe septic shock. Patients with HCAP are at variable risk for infection due

to MDR pathogens.

Page 27: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Diagnosis

NO UNVERSALLY ACCEPTED GOLD STANDARD DIAGNOSTIC CRITERIA!!!!!

Page 28: ventilator Associated Pneumonia -By Dr.Tinku Joseph

DIAGNOSIS

CLINICAL

MICROBIOLOGICAL

RADIOLOGICAL

Page 29: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Clinical presentation

Page 30: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Clinical Pulmonary Infection Score (CPIS)

Page 31: ventilator Associated Pneumonia -By Dr.Tinku Joseph

CPIS

Page 32: ventilator Associated Pneumonia -By Dr.Tinku Joseph

How do we diagnose ? 2-1-2

Page 33: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Microbiological diagnosisATS/IDSA

QUALITATIVE

CLINICAL CRITERIA

Page 34: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Respiratory secretion sampling

Page 35: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Bronchoscopic methods

Page 36: ventilator Associated Pneumonia -By Dr.Tinku Joseph

BAL V/S PSB

Page 37: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Non Bronchoscopic Methods

Page 38: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Bronchoscopic V/S Blind techniques

Page 39: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Difference between VAP and VAT

Page 40: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Role of biomarkers as diagnostic and prognostic markers of VAP

Page 41: ventilator Associated Pneumonia -By Dr.Tinku Joseph

RADIOLOGIC DIAGNOSIS

INFILTRATES

SOLITARY DIFFUSE NEW INFILTRATES

Page 42: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Radiological evidence of pneumonia

THINK BEFORE

LABELLING IT AS VAP!!

Page 43: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Radiological mimics of pneumonia in ICU patients

Chemical/Aspiration pneumonitis Atlectasis/lung collapse LVF ARDS Pleural effusion Pulmonary embolism Pulmonary hemorrhage Lung contusion Infiltrative tumor Radiation Pneumonitis Drug reaction Cryptogenic organizing pneumonia

Page 44: ventilator Associated Pneumonia -By Dr.Tinku Joseph

How will u treat VAP?

BEFORE CHOOSING ANTIBIOTIC, keep in mind on the following issues: Risk factors of the patient Was it early or late onset Virulence of organism Antibiotic resistance Cost

Page 45: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 46: ventilator Associated Pneumonia -By Dr.Tinku Joseph

TREATMENT PROTOCAL Initial therapy is empiric Start when VAP is suspected, Don’t delay Individualize to institution- Hospital epidemiologic data Drug cost and availability Individualize to patient-

-Early onset versus Late onset of VAP -Prior antibiotic use

-Underlying disease Renal, liver disease etc -Surveillance cultures -Use gram stain results if possible

Page 47: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Choice of antibiotic

Page 48: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific anti microbial considerations (MRSA)

Linezolid or Vancomycin is a necessary first choice for antistaphylococcal coverage .

Should be discontinued if MRSA is not isolated. Linezolid – 600 mg twice daily intravenously (IV; or

orally if or when the patient is able to receive oral medications)

Vancomycin – 15 to 20 mg/kg (based on actual body weight) IV every 8 to 12 hours for patients with normal renal function,

Page 49: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Alternative to Linezolid and vancomycin -: Clindamycin (600mg IV TID)

Telavancin: activity against MRSA. 10mg/kg IV OD. Other agents-: Daptomycin, Ceftaroline. Tigecycline-: It has been approved by the FDA for

skin and skin structure infections and intraabdominal infections caused by MRSA

Specific anti microbial considerations (MRSA)

Page 50: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific anti microbial considerations (MSSA)

If a sputum culture reveals MSSA empiric therapy for MRSA should be replaced with nafcillin (2 g IV every four hours) or oxacillin (2 g IV every four hours).

Page 51: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Monotherapy/ Combination therapy Avoid cephalosporins monotherapy in ICU settings -:

Presence of ESBL producing Enterobacteriaceae. Resistant organism.

Carbapenams-: Most reliable agent.Eg: meropneam, imipenam- cilastin, Ertapenam.

Doripenam-: Not much preferred.

Specific anti microbial considerations (Gram negative pathogens)

Page 52: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific anti microbial considerations (Legionella)

Patients who have diabetes mellitus, renal disease, structural lung disease, or have been recently treated with glucocorticoids may require coverage for Legionella spp (azithromycin or a fluoroquinolone).

Page 53: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific anti microbial considerations (Anaerobes)

Patients who have aspirated or had recent abdominal surgery may warrant coverage for anaerobes (clindamycin, beta-lactam-beta-lactamase inhibitor, or a carbapenem).

Page 54: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific anti microbial considerations

Antiinflammatory effects of macrolides Studies have shown good results in VAP (faster

resolution) Extended infusions: can potentially provide effective

therapy for pathogens with higher minimum inhibitory concentrations (MICs), may impede the emergence of resistance, and potentially provide a pharmacoeconomic benefit.

Page 55: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Aerosolized antibiotics

Aerosolized colistin, polymyxin, or aminoglycosides may be considered as potential additional antibiotics in patients with multidrug-resistant gram-negative bacilli.

Aerosolization may increase antibiotic concentrations at the site of infection and may be particularly useful for treatment of organisms that have high MICs to systemic antimicrobial agents.

Page 56: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP- Duration of treatment

The duration of therapy should be based upon the clinical response.

The standard duration of therapy in the past was 14 to 21 days in part because of a concern for difficult to treat pathogens (eg, Pseudomonas spp).

Page 57: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Treatment failure

Page 58: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Prevention of VAP

Page 59: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Specific practices have been shown to decrease VAP Strong evidence that a collaborative,

multidisciplinary approach incorporating many interventions is paramount

Intensive education directed at nurses and respiratory care practitioners resulted in a 57% decrease in VAP

Crit Care Med (2002)

Prevention of VAP

Page 60: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Conventional Infection control Aproach

Design of ICUAdequate space, lighting, proper function of ventilatory system, facilities for hand washing, Isolation room.StaffingEducation, Adequate number, quality, importance of personal cleanliness and attention to asceptic procedures.Hand washing and Hand rubbing with alcohol based solution.

Prevention of VAP

Page 61: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Conventional Infection control Aproach

Periodical bacterial monitoring policy. Specific prophylaxis- • use gloves, gown, mask. • Use of NIPPV • Minimize duration of MV, checking daily for readiness

to weaning/extubation• (Text book of criti care med. 5 the Edit.

MitchellP.FinkSHOEMAKER)

Prevention of VAP

Page 62: ventilator Associated Pneumonia -By Dr.Tinku Joseph

EFFECT OF VAP BUNDLE CARE

Page 63: ventilator Associated Pneumonia -By Dr.Tinku Joseph

VAP BUNDLE (VAP reduction rate44.5%)

VAP bundle(4) originated in 2005 from INSTITUTE OF HEALTH CARE IMPROVEMENT(IHI) & CDC

IN 2010 FIFTH COMPONENT DAILY ORAL CARE WITH CHLORHEXIDINE IS ADDED. 2011 -: Subglottic suction (criti. care 2012 vol. 40,no.1)

Page 64: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Prevention of VAP

Society of Healthcare Epidemiology (SHEA) and the Infectious Diseases Society of America (IDSA) issued updated practice recommendations to reduce the risk of ventilator-associated pneumonia (VAP) 2014

Page 65: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Patient positioning The supine position is an

independent risk factor for death in all ICU patients

HOB elevation to 30-45 degree especially during feeding prevent aspiration and 34% reduction in VAP (Lancet.nov.1999;354,1851-1858)

CDC recommends HOB 30-45° unless contraindicated

Prevention of VAP

Page 66: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Contraindications

Hypotension MAP <70Tachycardia >150CI <2.0Central line procedure Posterior circulation strokes Cervical spine instability use reverse trendelenburgSome femoral lines i.e.: IABP no higher than 30 degrees use reverse trendelenburgIncreased ICP, No higher than 30 degrees avoid hip flexion Proning

Page 67: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Reverse Trendelenburg

In full reverse Trendelenburg the foot of bed will read -12 degrees

Angle of head elevation is approximately 20 degrees (not 30 degrees) when at -12

Evaluate the individual clinical situation to assess if the patient can tolerate the addition of a small amount of Fowlers angle which may flex the hip

Page 68: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Daily Sedative Interruption and Daily Assessment of Readiness to Extubate

OVERSEDATION• Predisposes patients to:– Thromboemboli– Pressure ulcers– Gastric regurgitation and aspiration– VAP– Sepsis

• Consequences include:– Difficulty in monitoring neuro status– Increased use of diagnostic procedures– Increase ventilator days– Prolonged ICU and hospital stay

Page 69: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Daily Wake Up

Every patient must be awakened daily unless contraindicated!

Daily weaning assessments reduce the duration of mechanical ventilation.

Wean infusion to off in increments of 10-25% daily in order to perform a clinical assessment

Page 70: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Rebolus and restart infusion if the patient becomes symptomatic. Your new continuous IV dose should be lower than what you began with

Consider implementation of a sedation scale such as the Richmond Agitation Sedation Scale (RASS) scale to avoid over sedation.

Goal is to decrease sedation

Daily Wake Up

Page 71: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Stress ulcer prophylaxisSucralfate, H2 receptor blocker, proton pump inhibitor Increases gastric PH and minimize bacterial colonization that reduces the risk of VAP and GI bleeding

Sucralfate Decreases the VAP rate but increases the risk of GI bleeding by 4%.H2 receptor blockers/PP inhibitors Increase rate of VAP by increasing gastric PH leading to colonization of bacteria and decreases the risk of GI bleeding.

Page 72: ventilator Associated Pneumonia -By Dr.Tinku Joseph

H2 receptor blocker, PP inhibitor preferred over sucralfate

Am J Respir Crit Care Med. 2005;171(4):388-416

Page 73: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Deep Venous Thrombosis (DVT) Prophylaxis

There is increase risk of thomboembolism in mechanically ventilated patient.There is no any data association between DVT prophylaxis and decreasing rates of VAP.VAP rates decreased most dramatically in hospitals where all elements of the Ventilator Bundle were implemented, including this one.

Chest. 2004;126(3 Suppl):338S-400S.

Page 74: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Daily oral care

Dental plaque- due to absence of mechanical chewing and the saliva and they are reservoir for potential pathogens that causes VAP.Mechanical interventionTooth brushing , Rinsing of oral cavity to remove dental plaquePharmacological intervention0.12% CHLORHEXIDINE ORAL RINSE 15 ml twice daily Am J Crit Care. 2009 Sep;18(5):428-437

Page 75: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Oral decontamination 2%genta+2%Colistin+2%Vanco paste QID Selective decontamination of digestive

tract(SDD)- 2%polymyxin+tobra+Amphotericine paste oral

application QID. Solution 100mg poly+80mg tobra+500mg ampho

QID throu NG. IV Cefuroxime 1.5g TID first 4days.

Daily oral care

Promotes growth of resistant bacteria

Page 76: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Daily oral care• Best Practice??–Daily assessment to determine oral health–Brush q 12 hours to prevent plaque–Oral cleansing q 2-4 hours to promote healing

and maintain integrity of oral tissues–Use of an alcohol-free, antiseptic oral rinse to

prevent or reduce bacterial load of oropharynx–Routine suctioning of mouth to manage oral

secretions and minimize risk of aspiration–Use of a moisturizer Am J Crit Care (2005)

Page 77: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Gastric volume monitoring

standard clinical practice to monitor the patient's gastric residual volume at regular intervals and/or prior to increasing the infusion rate of gastric tube feeding

Hoping to minimize the risk of unrecognized gastric fluid accumulation and vomiting resulting in pneumonia

Page 78: ventilator Associated Pneumonia -By Dr.Tinku Joseph

several studies have shown that measurement of gastric residuals correlates poorly with aspiration risk and is associated with a decrease in calorie delivery.

A randomized trial has shown that the rate of VAP was not higher in patients who did not undergo monitoring of gastric residuals.

Gastric volume monitoring

Not recommended now a days

Page 79: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Probiotics

Not effective in preventing VAP as per various randomized controlled trials.

Most commonly used: Lactobacillus spp

Page 80: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Airway Management• Mechanical ventilation– Avoidance of Endotracheal intubation • Mask ventilation trials , NIPPV

• Minimize duration on MV– Orotracheal intubation • Nasotracheal intubation slightly increase the risk for VAP• Avoid Reintubations- increases risk of VAP 6 fold

(Am resp.criti car med.1995;152(1):137-141)

– Cuff management HVLP ETT cuff VAP rate 20% , LVHP ETT cuff VAP rate 20%

(Text book of criti. Care. 5 th Edit. Mitchell P.Fink SHOEMAKER) Maintain at 25-30 cm H2O

Page 81: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Airway Management• Suctioning– In-line suctioning using closed technique than open

technique– Normal saline• Should not be routinely used to suction pts• Causes desaturation• Does not increase removal of secretions• Can potentially dislodge bacteria from ETT to LRT• Should be used to rinse the suction catheter after suctioning• Maintaining adequate hydration, proper humidification of

ventilatory circuit, nebulizer, mucolytic agent can help to decrease the viscosity and eliminate the need for saline lavage

(Am. jour.crical care nurse 2007 vol. 27; 32-36:)

Page 82: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Suctioning

• Oral suction devices– Policies for use and storage not written– Harbor potentially pathogenic bacteria within 24 hours– 71% of nurses store the device in its packaging (STAMP)– Best practice???

• Change suction catheter every day• Rinse with sterile water or NS• Allow to air dry

Page 83: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Subglottal suctioning

Should be done using a 14 Fr sterile suction catheter:– Prior to ETT rotation– Prior to lying patient supine– Prior to Extubation

Page 84: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Continuous subglottic suctioning ETT with dedicated lumen to continuously or intermittently

suction above the cuff may reduce the risk of VAP.

Am J Respire cri car Med Oct.. 2010

Should be used for patients expected to require >48 or 72 hours of mechanical ventilation.

Cost more than standard endotracheal tubes and are not widely available

Subglottic drainage

Page 85: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Device for Continuous aspiration of subglottic secreations

Page 86: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Ventilator Circuit-Management

Vent circuit should not be routinely opened once ventilation is initiated

Disconnection of ventilation tubing can lead to loss of PEEP and alveolar de-recruitment

If circuit must be disconnected, clamp ETT with padded Kelly forceps to avoid PEEP loss

Page 87: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Expiratory condensation should be removed via the trap in the tubing

Inspiratory condensation – if clean, may be drained back into the water reservoir

Ventilator circuit can be changed weekly, unless it is soiled with blood or vomitus

Ventilator Circuit-Management

Page 88: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Ventilator Circuits Humidification Systems

Appropriate Humidification of inspired air

Active Humidification or Passive Humidification

Heat and Humidity Exchangers (HMEs) should not be routinely changed unless:– Visibly soiled– > 5 cm H2O auto-PEEP

Page 89: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Ventilator Circuits Humidification Systems

• Convert to Heated Humidification (HH) if:– Ventilated longer than 96 hours– Thick/bloody secretions– Resp. Acidosis– Air leak from chest tube or

around airway– VT < 300 cc or > 750 cc

Page 90: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Ventilator Circuits Humidification Systems

Page 91: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Silver-coated endotracheal tube

Silver-coated ETTs reduce the incidence of VAP but not of other important outcomes.

(NASCENT) trial.

Page 92: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 93: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Enteral Feedings

Early enternal feeding decrease bacterial colonization and rate of VAP

Bolus feeding should be avoided to minimize the risk of aspiration

Elevate HOB 30 - 45 degrees Routinely verify tube placement No CDC recommendations for:– Preferential use of small bore tubes– Continuous versus intermittent feeding– Post pyloric placement CDC (2003)

Page 94: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Patient turning

Routine turning of patient for every 2 hrs increase pulmonary drainage and decrease the risk of VAP.Use of beds with continues lateral rotation can decrease the incidence of pneumonia but do not decreases mortality or duration of MV

(critical care 2002;30(9):1983-1986)

Page 95: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Recent advances

National healthcare safety(NHSN) and CDC proposed- VAP terminology changed to VAC (ventilated associated conditions and complications) not necessarily limited VAP. VAP Surveillance definination algorithm. Chest x ray is not included , and diagnosis is mainly depend on worsening of gas exchange, clinical features, isolation of microorganism in resp.secreation.

Page 96: ventilator Associated Pneumonia -By Dr.Tinku Joseph

ETT- with continuous subglottic suction, ployurethrene cuff, Sponge cuff , Silver nitrate and antibiotic coated ETTs.

VAP industrial complex- kinetic beds, inlines suction catheters

VAP bunddle with 7 components – 5+ Replacing NGT to orogastric tube and Hand washing by health care personnel.

IMPLEMENTATION and ENFORCEMENT of VAP bundle

Recent advances

Page 97: ventilator Associated Pneumonia -By Dr.Tinku Joseph
Page 98: ventilator Associated Pneumonia -By Dr.Tinku Joseph

Top Related